Cyclo Therapeutics
Stock Forecast, Prediction & Price Target
Cyclo Therapeutics Financial Estimates
Cyclo Therapeutics Revenue Estimates
Cyclo Therapeutics EBITDA Estimates
Cyclo Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.58M N/A | $1.37M -13.24% | $1.07M -21.75% | Avg: $2.10M Low: $1.97M High: $2.24M avg. 95.77% | Avg: $16.26M Low: $15.21M High: $17.31M avg. 671.82% | Avg: $9.46M Low: $8.85M High: $10.07M avg. -41.80% | Avg: $67.2M Low: $62.86M High: $71.53M avg. 609.90% |
Net Income
% change YoY
| $-14.30M N/A | $-15.27M -6.81% | $-20.05M -31.26% | Avg: $-23.47M Low: $-13.06M High: $-7.83M avg. -17.05% | Avg: $-14.59M Low: $-6.20M High: $-1.46M avg. 37.82% | Avg: $-4.73M Low: $-5.13M High: $-4.33M avg. 67.56% | Avg: $3.26M Low: $2.99M High: $3.53M avg. 168.96% |
EBITDA
% change YoY
| $-14.23M N/A | $-15.75M -10.68% | $-20.03M -27.15% | Avg: $-2.10M Low: $-2.24M High: $-1.97M avg. 89.47% | Avg: $-16.26M Low: $-17.31M High: $-15.21M avg. -671.82% | Avg: $-9.46M Low: $-10.07M High: $-8.85M avg. 41.80% | Avg: $-67.2M Low: $-71.53M High: $-62.86M avg. -609.90% |
EPS
% change YoY
| -$2.25 N/A | -$1.81 19.55% | -$1.23 32.04% | Avg: -$0.59 Low: -$0.8 High: -$0.48 avg. 52.03% | Avg: -$0.24 Low: -$0.38 High: -$0.09 avg. 60.16% | Avg: -$0.29 Low: -$0.31 High: -$0.27 avg. -23.40% | Avg: $0.2 Low: $0.18 High: $0.22 avg. 168.96% |
Operating Expenses
% change YoY
| $15.69M N/A | $16.84M 7.32% | $21.03M 24.84% | Avg: $8.63M Low: $8.08M High: $9.19M avg. -58.93% | Avg: $66.66M Low: $62.36M High: $70.96M avg. 671.82% | Avg: $38.79M Low: $36.29M High: $41.30M avg. -41.80% | Avg: $275.44M Low: $257.67M High: $293.21M avg. 609.90% |
FAQ
What is Cyclo Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 64.32% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -13.06M, average is -23.47M and high is -7.83M.
What is Cyclo Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 333.92% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $1.97M, average is $2.10M and high is $2.24M.
What is Cyclo Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 64.44% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.8, average is -$0.59 and high is $-0.48.